Conventionally, hospital blood banks are managing donor screening by sending the sample to the central laboratory for CBC analysis, requiring waiting time for the report to be used in decision-making. Additionally, quality control demands testing of the derived blood components, which is also done in the central laboratory. RBC-concentrates and PLT concentrates often require pre-dilution, which is not only cumbersome but also associated with a high probability of errors. For efficient donor screening, blood banks are in search for rapid and precise CBC analysis, preferably from a finger-stick blood like other rapid tests. A method for testing of the blood products derived from the donated blood that allow direct sampling without dilution would greatly benefit quality assurance.
Boule 3-part systems standard model fulfills these requirements, while providing blood banks precise and accurate analyzing capability, without the need of sending samples away for analysis.